Extra-amniotic Foley catheter and prostaglandin E(2) gel for cervical ripening at term gestation.
OBJECTIVE
This study evaluated the efficacy of intravaginal prostaglandin E(2) gel in comparison with that of a Foley catheter for cervical ripening and induction of labor.


METHODS
Consecutive patients with unfavorable cervix requiring preinduction cervical ripening and induction of labor at term gestation were asked to participate in the study. One hundred and two patients were assigned to treatment with intravaginal prostaglandin E(2) gel (group 1) and 122 patients underwent the placement of an intracervical Foley catheter (group 2). After a maximum of three applications of intravaginal prostaglandin E(2) gel (18h) or after 18h from Foley catheter insertion oxytocin was administered to patients not in active labor. Labor profiles and pregnancy and neonatal outcome were compared between groups.


RESULTS
The groups were comparable in term of demographic characteristics, indications for induction of labor, Bishop score at admission. The induction to labor time and the induction to delivery time were similar between groups. The cesarean sections rate was higher in group 1 than in group 2 (26.5 versus 14.7%, P<0.05). This remained significant when the analysis was restricted to nulliparous patients (32.3 versus 14.2%). The incidence of urinary tract infections, chorioamnionitis, and febrile morbidity was similar between groups.


CONCLUSIONS
For preinduction cervical ripening, the Foley catheter is a valid alternative to the application of intravaginal prostaglandin E(2) gel and it is associated with a lower cesarean rate in nulliparous women.
Ghezzi
F
F
Department of Obstetrics and Gynecology, University of Insubria, Viale Borri 57, 21100, Varese, Italy. fabio.ghezzi@uninsubria.it
Massimo
F
F
Raio
L
L
Di Naro
E
E
Balestreri
D
D
Bolis
P
P
D000328:Adult; D002404:Catheterization; D002584:Cervix Uteri / Q000187:drug effects*; D002585:Cesarean Section / Q000706:statistics & numerical data; D036861:Delivery, Obstetric; D015232:Dinoprostone / Q000008:administration & dosage*; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007751:Labor, Induced; D010121:Oxytocin / Q000008:administration & dosage; D010298:Parity; D011247:Pregnancy; D011256:Pregnancy Outcome; D013997:Time Factors
D010121:Oxytocin; D015232:Dinoprostone